Maharashtra, India

Suresh Doke

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Evonik Operations Gmbh. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suresh Doke: Innovator in Pellet Technology

Introduction

Suresh Doke is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of pellet systems. His innovative approach has led to advancements that enhance the delivery of biologically active ingredients.

Latest Patents

Suresh Doke holds a patent for a Pellet and Multi-Unit Pellet System (MUPS). This invention features a pellet that contains a core with one or more biologically active ingredients, surrounded by a coating layer. The coating layer is composed of a mixture of two polymers, which are designed to optimize the release and effectiveness of the active ingredients. The MUPS, preferably in the form of a compressed tablet, contains multiple pellets, allowing for a controlled and efficient delivery system.

Career Highlights

Suresh Doke is currently employed at Evonik Operations GmbH, where he continues to work on innovative solutions in the pharmaceutical sector. His expertise in polymer chemistry and drug delivery systems has positioned him as a key player in his field.

Collaborations

Suresh collaborates with talented coworkers, including Shraddha Joshi and Aditi Poddar, who contribute to the development and refinement of his projects. Their teamwork fosters an environment of creativity and innovation.

Conclusion

Suresh Doke's contributions to pellet technology and drug delivery systems exemplify the impact of innovation in pharmaceuticals. His work not only advances scientific understanding but also enhances patient care through improved medication delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…